Ascendis Pharma Stock Forecast

Stock Price Forecast

The 15 analysts with 12-month price forecasts for Ascendis Pharma stock have an average target of 278.8, with a low estimate of 250 and a high estimate of 342. The average target predicts an increase of 16.55% from the current stock price of 239.22.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$250	$278.8	$271	$342
Change	+4.51%	+16.55%	+13.28%	+42.96%

Analyst Ratings

The average analyst rating for Ascendis Pharma stock from 15 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	7	6	6	6	6	5
Buy	10	9	9	10	10	10
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	17	15	15	16	16	15

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Luca Issi RBC Capital	RBC Capital	Buy Maintains $250 → $275	Buy	Maintains	$250 → $275	+14.96%	Mar 3, 2026
Leland Gershell Oppenheimer	Oppenheimer	Buy Maintains $246 → $262	Buy	Maintains	$246 → $262	+9.52%	Feb 12, 2026
Yun Zhong Wedbush	Wedbush	Buy Maintains $240 → $273	Buy	Maintains	$240 → $273	+14.12%	Feb 12, 2026
Tazeen Ahmad B of A Securities	B of A Securities	Strong Buy Maintains $246 → $260	Strong Buy	Maintains	$246 → $260	+8.69%	Jan 30, 2026
Eliana Merle Barclays	Barclays	Buy Initiates $342	Buy	Initiates	$342	+42.96%	Jan 28, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.43B

from 720.13M

98.02%

from 720.13M

Revenue Next Year

2.04B

from 1.43B

43.13%

from 1.43B

EPS This Year

4.80

from -3.76

EPS Next Year

11.05

from 4.80

130.30%

from 4.80

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Jan 1, 2023	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	7.78M	51.17M	266.72M	363.64M	720.13M	1.43B	2.04B
Revenue Growth	11.87%	557.93%	421.20%	36.34%	98.03%	98.02%	43.13%
EPS	-7.00	-10.40	-8.55	-6.53	-3.76	4.80	11.05
EPS Growth	-	-	-	-	-	-	130.30%
Forward PE	-	-	-	-	-	42.85	18.61
No. Analysts	-	-	-	-	-	19	19

Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	1.6B	2.5B
Avg	1.4B	2.0B
Low	1.2B	1.6B

Revenue Growth

Revenue Growth	2026	2027
High	122.6%	74.4%
Avg	98.0%	43.1%
Low	62.7%	13.5%

EPS Forecast

EPS	2026	2027
High	8.73	18.44
Avg	4.80	11.05
Low	1.84	4.84

EPS Growth

EPS Growth	2026	2027
High	-	284.1%
Avg	-	130.3%
Low	-	0.9%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.